4.7 Article

MUC1-C integrates aerobic glycolysis with suppression of oxidative phosphorylation in triple-negative breast cancer stem cells

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast Cancer

Nami Yamashita et al.

Summary: In certain cancer cells, the chromatin remodeling complex SWI/SNF PBAF's subunit polybromo-1 (PBRM1) drives DNA damage resistance and immune evasion through unclear mechanisms. This study found that MUC1-C is necessary for PBRM1 expression in triple-negative breast cancer (TNBC) cells, and the two proteins form a nuclear complex. Transcriptional and chromatin accessibility analysis showed that MUC1-C and PBRM1 increase the expression of STAT1 and IRF1 by enhancing chromatin accessibility on their respective genes, as well as other genes involved in DNA damage resistance and immune evasion.

MOLECULAR CANCER RESEARCH (2023)

Article Oncology

MUC1-C dictates neuroendocrine lineage specification in pancreatic ductal adenocarcinomas

Zhou Luan et al.

Summary: MUC1-C drives the progression of PDAC by integrating IFN signaling and pluripotency with NE dedifferentiation, and may serve as a potential target for the treatment of poorly differentiated pancreatic NE carcinomas.

CARCINOGENESIS (2022)

Article Oncology

MUC1-C Dictates JUN and BAF-Mediated Chromatin Remodeling at Enhancer Signatures in Cancer Stem Cells

Atrayee Bhattacharya et al.

Summary: The MUC1-C protein promotes the dedifferentiation of castrate-resistant prostate cancer and triple-negative breast cancer cells. It induces global changes in chromatin architecture through interactions with JUN/AP-1 and ARID1A/BAF complexes, contributing to the formation of the cancer stem cell state.

MOLECULAR CANCER RESEARCH (2022)

Review Oncology

Treatment landscape of triple-negative breast cancer - expanded options, evolving needs

Giampaolo Bianchini et al.

Summary: Recent advances in omics technologies have improved our understanding of the heterogeneity and microenvironment of triple-negative breast cancers (TNBCs), supporting a view of this breast cancer subtype as an ecosystem that encompasses both intrinsic and extrinsic features of cancer cells. The authors of this Review describe the current and upcoming therapeutic landscape of TNBC and discuss how an integrated view of the TNBC ecosystem can provide improved opportunities for tailoring treatment.

NATURE REVIEWS CLINICAL ONCOLOGY (2022)

Article Multidisciplinary Sciences

A non-dividing cell population with high pyruvate dehydrogenase kinase activity regulates metabolic heterogeneity and tumorigenesis in the intestine

Carlos Sebastian et al.

Summary: This study reveals that the histone deacetylase SIRT6 controls tumor initiation in intestinal cancer through regulating glucose metabolism. The loss of SIRT6 leads to an increase in the number of intestinal stem cells (ISCs), resulting in enhanced tumor initiating potential. The researchers found a metabolic compartmentalization within the intestinal epithelium and adenomas, where a rare population of cells exhibit features of Warburg-like metabolism characterized by high pyruvate dehydrogenase kinase (PDK) activity. These cells are quiescent cells expressing +4 ISCs and enteroendocrine markers, and their active glycolysis suppresses ROS accumulation and enhances their stem cell and tumorigenic potential.

NATURE COMMUNICATIONS (2022)

Article Oncology

Targeting MUC1-C Suppresses Chronic Activation of Cytosolic Nucleotide Receptors and STING in Triple-Negative Breast Cancer

Nami Yamashita et al.

Summary: Triple-negative breast cancers (TNBCs) are difficult to treat tumors with limited therapeutic options, including cytotoxic agents and olaparib. Research shows that the oncogenic MUC1-C protein can activate DNA damage resistance, making it a target for overcoming obstacles in TNBC treatment.

CANCERS (2022)

Review Biochemistry & Molecular Biology

Addiction of Cancer Stem Cells to MUC1-C in Triple-Negative Breast Cancer Progression

Nami Yamashita et al.

Summary: TNBC is an aggressive malignancy with limited treatment options and few insights into its druggable targets. MUC1-C has been identified as a crucial protein in TNBC CSCs, inducing EMT, epigenetic reprogramming, and chromatin remodeling. Targeting MUC1-C may lead to the elimination of TNBC CSCs and provide new treatment options for this difficult-to-treat cancer.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Pharmacology & Pharmacy

The significance of glycolysis in tumor progression and its relationship with the tumor microenvironment

Daoying Zhou et al.

Summary: Glycolysis plays a significant role in tumor growth and development, particularly its association with the tumor microenvironment (TME) and its impact on lactate accumulation and immunosuppression in the TME. Studying the interaction between glycolysis and TME can provide new insights for clinical treatment of tumors.

FRONTIERS IN PHARMACOLOGY (2022)

Article Oncology

Dependence on the MUC1-C Oncoprotein in Classic, Variant, and Non-neuroendocrine Small Cell Lung Cancer

Atsushi Fushimi et al.

Summary: MUC1-C protein is activated in pulmonary epithelial cells and plays a crucial role in promoting the growth and development of small cell lung cancer (SCLC) cells through activation of the MYC pathway. Furthermore, the MUC1-C->MYC->NOTCH2 network is essential for self-renewal capacity and tumorigenicity of SCLC cells.

MOLECULAR CANCER RESEARCH (2022)

Article Biochemistry & Molecular Biology

Addiction of Merkel cell carcinoma to MUC1-C identifies a potential new target for treatment

Yoshihiro Morimoto et al.

Summary: This study discovered that MUC1-C is broadly expressed in MCCs and has higher expression levels in MCPyV-positive MCCs. MUC1-C regulates signaling pathways related to RNA synthesis, processing, and transport and interacts with MYCL to drive MCC progression. It is also necessary for the expression of pluripotency factors and NE lineage transcription factors. MUC1-C is crucial for MCC cell survival by suppressing DNA replication stress, the p53 pathway, and apoptosis. Targeting MUC1-C inhibits MCC self-renewal capacity and tumorigenicity, making it a potential target for MCC treatment.

ONCOGENE (2022)

Review Biochemistry & Molecular Biology

Revisited Metabolic Control and Reprogramming Cancers by Means of the Warburg Effect in Tumor Cells

Abekura Fukushi et al.

Summary: Aerobic glycolysis is a characteristic of many human cancers, playing a crucial role in the growth, invasion, immune escape, and drug resistance of cancer cells. The glycolysis pathway consists of multiple enzymatic reactions, with increased levels of glycolytic proteins and enzymatic activities observed in cancer cells. In the Warburg effect, cancer cells rely on glycolysis to generate energy instead of oxidative phosphorylation. The understanding of the Warburg effect can lead to the development of targeted therapies for cancer treatment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Biochemistry & Molecular Biology

Searching for the Metabolic Signature of Cancer: A Review from Warburg's Time to Now

Pierre Jacquet et al.

Summary: This review explores the evolving understanding of tumor cell metabolism, particularly glycolytic and oxidative metabolism, tracing its evolution from the pioneering work of Otto Warburg. Misinterpretations of Warburg's work have hindered the understanding of tumor cell metabolism, leading to new concepts like metabolic switch and metabolic reprogramming. The metabolic signature of cancer is complex and cannot be simplified to a single factor, but is expressed at the tissue level through cells' ability to dynamically explore a vast metabolic landscape in heterogeneous environments.

BIOMOLECULES (2022)

Article Cell Biology

?Np63/p73 drive metastatic colonization by controlling a regenerative epithelial stem cell program in quasi-mesenchymal cancer stem cells

Arthur W. Lambert et al.

Summary: This study isolated highly enriched populations of human breast cancer stem cells (CSCs) using cell-surface expression of integrin b4 (ITGB4), and identified the gene regulatory network operating in ITGB4+ CSCs. The transcriptional program controlled by DNp63 in CSCs was found to be distinct from that in normal basal mammary stem cells, and instead resembled a regenerative epithelial stem cell response to wounding. Additionally, the quasi-mesenchymal CSCs repurpose this program to drive metastatic colonization via autocrine EGFR signaling.

DEVELOPMENTAL CELL (2022)

Article Biochemistry & Molecular Biology

Inhibition of glucose transport synergizes with chemical or genetic disruption of mitochondrial metabolism and suppresses TCA cycle-deficient tumors

Kellen Olszewski et al.

Summary: In this study, researchers developed a series of potent, orally bioavailable inhibitors of class I glucose transporters (GLUTs). The representative compound KL-11743 specifically blocks glucose metabolism, leading to an increase in oxidative phosphorylation in the mitochondria. Disrupting mitochondrial metabolism in combination with KL-11743 causes synthetic lethality, and patient-derived xenograft models demonstrate the vulnerability of succinate dehydrogenase A (SDHA)-deficient cancers to GLUT inhibitors.

CELL CHEMICAL BIOLOGY (2022)

Review Cell Biology

Complex IV-The regulatory center of mitochondrial oxidative phosphorylation

Bernhard Kadenbach

Summary: ATP serves as the universal energy currency in all living cells, mainly synthesized in mitochondria through oxidative phosphorylation. Cytochrome c oxidase (COX) acts as the regulatory center of OXPHOS, regulated by various effectors such as feedback inhibition by ATP and phosphorylation. In the relaxed state, ATP inhibition of phosphorylated and dimeric COX helps maintain a low and healthy mitochondrial membrane potential, preventing the formation of ROS.

MITOCHONDRION (2021)

Article Oncology

MUC1-C Activates the BAF (mSWI/SNF) Complex in Prostate Cancer Stem Cells

Masayuki Hagiwara et al.

Summary: MUC1-C associates with E2F1 and activates a novel pathway related to prostate cancer stem cell function.

CANCER RESEARCH (2021)

Review Biochemistry & Molecular Biology

Hexokinase 2 in Cancer: A Prima Donna Playing Multiple Characters

Francesco Ciscato et al.

Summary: Hexokinases, particularly Hexokinase 2 (HK2), play a critical role in glucose metabolism and are highly expressed in insulin-sensitive tissues and neoplastic cells. In addition to its enzymatic activity, HK2 can regulate autophagy and cell death, as well as intracellular Ca2+ fluxes, at the mitochondria-associated membranes (MAMs). Targeting HK2 subcellular localization in MAMs may offer a promising anti-tumor strategy by disrupting its functions in metabolic and survival pathways.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Oncology

Beyond the Double-Strand Breaks: The Role of DNA Repair Proteins in Cancer Stem-Cell Regulation

Jacqueline Nathansen et al.

Summary: Cancer stem cells (CSCs) are a highly tumorigenic cell population capable of repopulating tumors and causing relapses even after successful therapy. They possess enhanced DNA repair mechanisms that not only contribute to therapy resistance, but also play crucial roles in tumor evolution and treatment resistance. The role of DNA repair proteins in CSCs extends beyond DNA repair, impacting transcription regulation, signaling pathways, cellular stress responses, and immune reactions towards tumor cells. Targeting DNA repair pathways in CSCs holds promise for personalized therapies and sensitizing CSCs to anti-cancer treatments.

CANCERS (2021)

Review Biochemistry & Molecular Biology

Metabolic changes in triple negative breast cancer-focus on aerobic glycolysis

J. R. Dev Arundhathi et al.

Summary: Triple negative breast cancer (TNBC) has the worst prognosis among breast cancer subtypes and standard chemotherapy is the main treatment. Metabolic reprogramming, specifically altered glycolysis, plays a crucial role in TNBC progression, offering potential therapeutic targets.

MOLECULAR BIOLOGY REPORTS (2021)

Article Biochemistry & Molecular Biology

MUC1-C activates the PBAF chromatin remodeling complex in integrating redox balance with progression of human prostate cancer stem cells

Masayuki Hagiwara et al.

Summary: The study demonstrates that MUC1-C induces the expression of PBRM1, ARID2, and BRD7 by E2F1 activation, subsequently influencing the PBAF pathway and NRF2 antioxidant gene transcriptome in PC cells. This pathway plays a crucial role in regulating ROS levels, pluripotency factor expression, and cancer stem cell state.

ONCOGENE (2021)

Review Cell Biology

Redox-Mediated Regulation of Mitochondrial Biogenesis, Dynamics, and Respiratory Chain Assembly in Yeast and Human Cells

Stefan Geldon et al.

Summary: Mitochondria are double-membrane organelles that participate in cellular respiration through the oxidative phosphorylation system, with most proteins encoded in the nucleus and imported to different compartments. The intermembrane space of mitochondria contains diverse proteins crucial for the maturation and function of electron transport chain complexes.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Biochemistry & Molecular Biology

UCell: Robust and scalable single-cell gene signature scoring

Massimo Andreatta et al.

Summary: UCell is an R package designed for evaluating gene signatures in single-cell datasets. It offers robust signature scores based on the Mann-Whitney U statistic, requiring less computing time and memory compared to other methods. UCell can handle large datasets in minutes and can interact directly with Seurat objects.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2021)

Review Oncology

Oncogenic pathways and the electron transport chain: a dangeROS liaison

Vittoria Raimondi et al.

BRITISH JOURNAL OF CANCER (2020)

Review Biochemistry & Molecular Biology

2-Deoxy-d-Glucose and Its Analogs: From Diagnostic to Therapeutic Agents

B. Pajak et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Multidisciplinary Sciences

MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer

Yota Yasumizu et al.

NATURE COMMUNICATIONS (2020)

Review Multidisciplinary Sciences

Metabolic reprogramming and cancer progression

Brandon Faubert et al.

SCIENCE (2020)

Review Oncology

Metabolic Reprogramming in Triple-Negative Breast Cancer

Sun Xiangyu et al.

FRONTIERS IN ONCOLOGY (2020)

Review Cell Biology

Role of Mitochondria in Cancer Stem Cell Resistance

Jose Manuel Garcia-Heredia et al.

Article Medicine, Research & Experimental

MUC1-C drives stemness in progression of colitis to colorectal cancer

Wei Li et al.

JCI INSIGHT (2020)

Article Medicine, Research & Experimental

Regulation of glycolysis and the Warburg effect in wound healing

Roohi Vinaik et al.

JCI INSIGHT (2020)

Review Cell Biology

Mitochondria in cancer

Debora Grasso et al.

CELL STRESS (2020)

Review Oncology

Metabolic reprogramming in triple-negative breast cancer

Zhanyu Wang et al.

CANCER BIOLOGY & MEDICINE (2020)

Article Biochemistry & Molecular Biology

Scrublet: Computational Identification of Cell Doublets in Single-Cell Transcriptomic Data

Samuel L. Wolock et al.

CELL SYSTEMS (2019)

Article Oncology

Targeting MUC1-C Inhibits TWIST1 Signaling in Triple-Negative Breast Cancer

Tsuyoshi Hata et al.

MOLECULAR CANCER THERAPEUTICS (2019)

Review Biochemistry & Molecular Biology

MYC-induced metabolic stress and tumorigenesis

Adam J. Wolpaw et al.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2018)

Article Biochemistry & Molecular Biology

Recovering Gene Interactions from Single-Cell Data Using Data Diffusion

David van Dijk et al.

Review Biochemistry & Molecular Biology

Assembly of mammalian oxidative phosphorylation complexes I-V and supercomplexes

Alba Signes et al.

MITOCHONDRIAL DISEASES (2018)

Article Biotechnology & Applied Microbiology

Integrating single-cell transcriptomic data across different conditions, technologies, and species

Andrew Butler et al.

NATURE BIOTECHNOLOGY (2018)

Review Genetics & Heredity

Mitochondrial DNA Transcription and Its Regulation: An Evolutionary Perspective

Gilad Barshad et al.

TRENDS IN GENETICS (2018)

Review Oncology

Cancer Stem Cell Metabolism and Potential Therapeutic Targets

Vusala Snyder et al.

FRONTIERS IN ONCOLOGY (2018)

Article Multidisciplinary Sciences

Pan-cancer analysis of transcriptional metabolic dysregulation using The Cancer Genome Atlas

S. R. Rosario et al.

NATURE COMMUNICATIONS (2018)

Article Biochemistry & Molecular Biology

MUC1-C activates BMI1 in human cancer cells

M. Hiraki et al.

ONCOGENE (2017)

Article Biochemistry & Molecular Biology

Targeting MUC1-C inhibits the AKT-S6K1-eIF4A pathway regulating TIGAR translation in colorectal cancer

Rehan Ahmad et al.

MOLECULAR CANCER (2017)

Review Biochemistry & Molecular Biology

Mitochondria and Cancer

Sejal Vyas et al.

Review Cell Biology

Redox Regulation in Cancer Stem Cells

Shijie Ding et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2015)

Article Biochemistry & Molecular Biology

The Molecular Signatures Database Hallmark Gene Set Collection

Arthur Liberzon et al.

CELL SYSTEMS (2015)

Article Medicine, Research & Experimental

MYC and Mitochondrial Biogenesis

Fionnuala Morrish et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)

Article Biotechnology & Applied Microbiology

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Michael I. Love et al.

GENOME BIOLOGY (2014)

Article Biochemical Research Methods

STAR: ultrafast universal RNA-seq aligner

Alexander Dobin et al.

BIOINFORMATICS (2013)

Review Biochemistry & Molecular Biology

Mitochondrial transcription factor A regulates mitochondrial transcription initiation, DNA packaging, and genome copy number

Christopher T. Campbell et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2012)

Review Biochemistry & Molecular Biology

Physiological Roles of Mitochondrial Reactive Oxygen Species

Laura A. Sena et al.

MOLECULAR CELL (2012)

Review Oncology

Mitochondria and cancer

Douglas C. Wallace

NATURE REVIEWS CANCER (2012)

Article Multidisciplinary Sciences

MUC1-C Oncoprotein Regulates Glycolysis and Pyruvate Kinase m2 Activity in Cancer Cells

Michio Kosugi et al.

PLOS ONE (2011)

Article Biochemistry & Molecular Biology

MUC1-C Oncoprotein Promotes STAT3 Activation in an Autoinductive Regulatory Loop

Rehan Ahmad et al.

SCIENCE SIGNALING (2011)

Article Biochemistry & Molecular Biology

The epithelial-mesenchymal transition generates cells with properties of stem cells

Sendurai A. Mani et al.

Article Biochemistry & Molecular Biology

MTERF3 is a negative regulator of mammalian mtDNA transcription

Chan Bae Park et al.